Pharmaceutical Technology2 天
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.
AbbVie: FDA Approves Emblaveo - Metronidazole Combination For Complicated Intra-Abdominal ...
AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...
AbbVie says FDA approves Emblaveo in combination with metronidazole in adults
AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...